Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

2,4,6-trimethyl-N-((3'-(methylsulfonyl)-4-biphenylyl)methyl)-N-((5-(trifluoromethyl)-2-furanyl)methyl)benzenesulfonamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
2,4,6-trimethyl-N-((3'-(methylsulfonyl)-4-biphenylyl)methyl)-N-((5-(trifluoromethyl)-2-furanyl)methyl)benzenesulfonamide
Unique ID
C549350
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C549350
Entry Term(s)
GSK 2033
GSK-2033
GSK2033
Registry Numbers
0
Heading Mapped to
*Benzenesulfonamides
Frequency
7
Note
a liver X receptor antagonist; structure in first source
Source
J Med Chem 2010 Apr 22;53(8):3412-6
Date of Entry
2010/05/13
Revision Date
2023/06/22
2,4,6-trimethyl-N-((3'-(methylsulfonyl)-4-biphenylyl)methyl)-N-((5-(trifluoromethyl)-2-furanyl)methyl)benzenesulfonamide Preferred
GSK 2033 Narrower
page delivered in 0.005s